Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-06-10
2009-08-11
Oh, Taylor Victor (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S370000, C514S438000, C514S464000, C514S466000, C546S139000, C546S304000, C548S190000, C548S400000, C548S453000, C544S242000, C544S358000, C540S582000
Reexamination Certificate
active
07572817
ABSTRACT:
The present invention concerns compounds of formula (I), and pharmaceutically acceptable salts or solvates thereof, or solvates of such salts, which compounds inhibit carboxypeptidase U and thus can be used in the prevention and treatment of diseases where inhibition of carboxypeptidase U is beneficial. In further aspects, the invention relates to compounds of the invention for use in therapy; to processes for preparation of such new compounds; to pharmaceutical compositions containing at least one compound of the invention, or a pharmaceutically acceptable salt or solvate thereof, as active ingredient; and to the use of the active compounds in the manufacture of medicaments for the medical use indicated above.
REFERENCES:
patent: WO-00/66557 (2000-11-01), None
AstraZeneca AB
Morgan & Lewis & Bockius, LLP
Oh Taylor Victor
LandOfFree
2,5-disubstituted 3-mercaptopentanoic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,5-disubstituted 3-mercaptopentanoic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,5-disubstituted 3-mercaptopentanoic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4108205